Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road
Company

Italian diagnostics company DiaSorin to build manufacturing site in Shanghai

September 24, 2020


Abstract : Italian medical diagnostics company DiaSorin announced on Wednesday that it has reached a binding agreement with the government of Baoshan District in the north of Shanghai, the biggest city in China, on establishing its first manufacturing and research site there.

ROME, Sept. 23 (Xinhua) -- Italian medical diagnostics company DiaSorin announced on Wednesday that it has reached a binding agreement with the government of Baoshan District in the north of Shanghai, the biggest city in China, on establishing its first manufacturing and research site there.

DiaSorin has been operating in China in a joint venture with the local government for over 10 years. It currently serves over 1,000 hospitals in the country for the diagnosis of prenatal infections, the statement said.

Once the new plant in Shanghai is completed, DiaSorin will employ over 300 people there, the Italian company said.

"We strongly believe that a stronger local presence will allow us to... access tremendous new market opportunities," commented Chen Even, chief commercial officer (CCO) of the DiaSorin Group.

"Our presence in China has significantly increased since 2005, when we started to operate in the country," commented Carlo Rosa, chief executive officer (CEO) of the DiaSorin Group. "We think that the time has come to grow further in this important market."

Rosa added that "it is strategic for us to ...strengthen our presence in growing and strategic markets like China, where hundreds of billions of dollars will be invested by the government in the next 10 years to further improve the health care system."

Headquartered in Italy, DiaSorin develops, produces and markets reagent kits used by diagnostics laboratories worldwide. Enditem

Scan the QR code and push it to your mobile phone

Keyword: Shanghai DiaSorin manufacturing site

Reading:

Myanmar permits 6 more foreign enterprises to invest in Yangon region

BRICS bank issues bond to support COVID-19 response

Economic Watch: China's think tank sees key trends shaping future of global economy

China innovation, entrepreneurship fair kicks off in Guangzhou

JinkoSolar plans listing its Jiangxi subsidiary on SSE STAR Market

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial